Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Advanced Cardiac Therapeutics Inc.

This article was originally published in Start Up

Executive Summary

For more than 20 years, cardiac ablation catheter development has focused on two major areas: three-dimensional mapping systems to determine a specific patient's heart dimensions to help map arrhythmias and guide catheters, and mechanisms for catheter positioning and steerability. Little attention has been devoted to ablation lesion success and safety assessment. Advanced Cardiac Therapeutics Inc. aims to fill this gap with its intelligent, in-tissue, temperature-sensing irrigated ablation catheter. The device features a chip-based radiometry system to provide physicians with real-time in-tissue temperature when performing irrigated cardiac ablations.

Related Content


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts